GHRP-2 Acetate

Description

GHRP-2 (Growth Hormone Releasing Peptide-2), also known as Pralmorelin, is a synthetic hexapeptide acting as a growth hormone secretagogue (GHS). It belongs to the second generation of GHRPs and is widely recognized in literature as one of the most potent stimulators of growth hormone release available.

Mechanistically, GHRP-2 acts as an agonist of the ghrelin receptor (GHS-R1a). However, unlike its predecessor GHRP-6, GHRP-2 is significantly more selective. Research indicates it triggers a massive pulse of growth hormone (and subsequently IGF-1) with a much milder effect on appetite stimulation. It is often the “compound of choice” for researchers seeking maximum GH output without the extreme hunger response associated with first-generation secretagogues.

Key Research Applications

• Maximum GH Amplitude: GHRP-2 is investigated for its high efficacy. Studies in test subjects have shown it can induce GH levels 10-15 times higher than baseline. It is often used as a “positive control” in pituitary function studies because of its reliability in forcing a secretion event.

• Appetite & Catabolic States: While less intense than GHRP-6, GHRP-2 still retains some orexigenic (appetite-stimulating) properties. This makes it a primary subject of research for cachexia (wasting syndrome) and sarcopenia, where researchers aim to simultaneously stimulate muscle anabolism and food intake in catabolic subjects.

• Cardioprotection: Emerging research suggests GHRP-2 binds to receptors in cardiac tissue. Animal models of ischemia-reperfusion injury have demonstrated that GHRP-2 administration may protect heart muscle cells (cardiomyocytes) from apoptosis and reduce infarct size.

⚠️ FOR RESEARCH PURPOSES ONLY This product is intended for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic use. Handle with care and adhere to all laboratory safety protocols.